Jung, J. Y., Ryu, M., Ryoo, B., Han, B., Cho, J. W., Lim, M. S., . . . Zang, D. Y. Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients after Failed Docetaxel and S-1. Wiley.
Chicago Style (17th ed.) CitationJung, Joo Young, et al. Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients After Failed Docetaxel and S-1. Wiley.
MLA (9th ed.) CitationJung, Joo Young, et al. Second-Line Irinotecan, Leucovorin, and 5-Fluorouracil for Gastric Cancer Patients After Failed Docetaxel and S-1. Wiley.
Warning: These citations may not always be 100% accurate.